RE:RE:RE:Q&AIt was nice to see a good turn out for the Q&A. I thought there was good questions asked. Thanks to those who stepped up and asked them. The webinar could have been set up for a bit longer this time around, because of years of questions that have gone unanswered. Dr Beiber may have been a good addition this time around. Would have liked to hear his perspective on the company. What changes he would like to see. Seeing that nothing has come of his analysis so far (if ever)
Sounds like a company from China is interested in pet deal, and human use of their product for diabetes is still something this company could pursue.
Thought it was interesting to hear Howard say that it was up to the company that owned the rights to TFC-1067, had the option to use it for skin lightner and not just for dark spots, however was a sensitive market to get into.
Lots more in the pipeline with anti aging trials going on, and Anti-viral is a huge market. Lots to look forward to. It is very frustrating because everything moves at a snails pace. Howard said the companies they deal with are so knowledgeable that the info they want is very indepth before moving forward.